What is Borregaard ASA?
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally.
BRRDF · Verdict
Moderate reward · moderate risk
BRRDF stands out on cash flow and balance sheet, but watch the profitability signal.
Based on 88% data coverage
BRRDF · Verdict
7% free-cash-flow margin
Interest covered 9.5×
Above average
8% net margin · 11% ROE
Model-based scoring. For information only — not financial advice.
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company is listed on the PINK in USA, operating in the Basic Materials sector, with a market capitalisation of 1.92B, and a P/E ratio of 29.5x.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.
A short list of Specialty Chemicals names that are close enough in size to make side-by-side comparison useful.